China Universal Asset Management Company’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
PCM
MAP
EAM
KCM
PFSRSONJ
KOCAA
LA
China Universal Asset Management Company's KYMR Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Kymera Therapeutics (KYMR) stake by 9.6% in Q2 2026, selling an estimated $120K and leaving 13,091 shares worth $1.5M. The position accounts for 0.09% of the portfolio, ranked #160.
China Universal Asset Management Company first reported a position in KYMR in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.91M in Q4 2025. 49 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.
- China Universal Asset Management Company held 13,091 shares of Kymera Therapeutics worth $1.5M as of Q2 2026.
- China Universal Asset Management Company sold 1,397 Kymera Therapeutics shares in Q2 2026, an estimated $120K.
- Kymera Therapeutics made up 0.09% of China Universal Asset Management Company's portfolio in Q2 2026, its #160 holding.
- China Universal Asset Management Company first reported a position in Kymera Therapeutics in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Kymera Therapeutics position peaked at $1.91M in Q4 2025.
- 49 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.